Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07227766 · ClinicalTrials.gov registry record · NA
Dietary Reversal of the Reprometabolic Syndrome
A NA study of Obesity & Overweight and Infertility, Female, sponsored by University of Colorado, Denver.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07227766: Active NA study of Obesity & Overweight and Infertility, Female, sponsored by University of Colorado, Denver.
NCT07227766 is a NA study of Obesity & Overweight and Infertility, Female that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 30 participants, below the 114-participant average among 28 other Obesity & Overweight trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07227766, a NA study of Obesity & Overweight and Infertility, Female, is active but no longer recruiting, sponsored by University of Colorado, Denver.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study proposes to test the specific question that a eucaloric, low-fat diet given to women with obesity will result in an increase in reproductive hormones.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Low-fat diet
Study Locations (1)
Colorado
- University of Colorado School of Medicine - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-08-10 |
| Est. Completion | 2029-12-30 |
| Phase | NA |
What the registry record for NCT07227766 still lists
NCT07227766 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 114-participant average among 28 other Obesity & Overweight trials with a reported enrollment target (74% lower).
The record links to 2 conditions, with Obesity & Overweight appearing as the primary indexed condition, and to 1 intervention - of which Low-fat diet is the first listed.
NCT07227766 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT07227766 about?
NCT07227766 is a clinical study titled "Dietary Reversal of the Reprometabolic Syndrome". This study proposes to test the specific question that a eucaloric, low-fat diet given to women with obesity will result in an increase in reproductive hormones.
What is the current status of trial NCT07227766?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-08-10. Estimated completion is 2029-12-30.
What conditions does trial NCT07227766 study?
This clinical trial studies the following conditions: Obesity & Overweight, Infertility, Female.
What interventions are being tested in trial NCT07227766?
The interventions under investigation include: Low-fat diet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07227766?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07227766 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity & Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07227766's enrollment target sits among peer trials
30 24th of 28 higher than 5 of 28 other Obesity & Overweight trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity & Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity
RECRUITING · NA
-
Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment
RECRUITING · NA
-
Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy
RECRUITING · NA
-
Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
RECRUITING · NA
-
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
RECRUITING · NA
-
Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI